Capital Research Global Investors Purchases 68,826 Shares of Marsh & McLennan Companies, Inc. $MRSH

Capital Research Global Investors raised its holdings in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 0.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,861,067 shares of the financial services provider’s stock after purchasing an additional 68,826 shares during the quarter. Capital Research Global Investors’ holdings in Marsh & McLennan Companies were worth $1,987,301,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Capital World Investors raised its position in shares of Marsh & McLennan Companies by 0.5% in the 3rd quarter. Capital World Investors now owns 17,702,898 shares of the financial services provider’s stock worth $3,567,410,000 after acquiring an additional 92,767 shares in the last quarter. Capital International Sarl lifted its position in Marsh & McLennan Companies by 3.3% during the 3rd quarter. Capital International Sarl now owns 67,496 shares of the financial services provider’s stock worth $13,602,000 after acquiring an additional 2,137 shares during the period. Capital International Ltd. CA lifted its holdings in shares of Marsh & McLennan Companies by 3.1% during the third quarter. Capital International Ltd. CA now owns 25,645 shares of the financial services provider’s stock worth $5,168,000 after purchasing an additional 781 shares during the period. Capital International Inc. CA lifted its stake in Marsh & McLennan Companies by 20.7% during the 3rd quarter. Capital International Inc. CA now owns 667,621 shares of the financial services provider’s stock valued at $134,546,000 after acquiring an additional 114,547 shares during the period. Finally, Capital International Investors raised its holdings in shares of Marsh & McLennan Companies by 1.2% during the third quarter. Capital International Investors now owns 18,590,697 shares of the financial services provider’s stock worth $3,745,889,000 after purchasing an additional 221,033 shares during the last quarter. Institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Stock Performance

Shares of MRSH opened at $179.92 on Tuesday. The firm has a market capitalization of $87.10 billion, a PE ratio of 21.34, a PEG ratio of 2.49 and a beta of 0.74. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 1.20. Marsh & McLennan Companies, Inc. has a twelve month low of $170.37 and a twelve month high of $248.00.

Marsh & McLennan Companies (NYSE:MRSH) last announced its quarterly earnings results on Thursday, January 29th. The financial services provider reported $2.12 EPS for the quarter, topping the consensus estimate of $1.97 by $0.15. The firm had revenue of $6.60 billion for the quarter, compared to analyst estimates of $6.52 billion. Marsh & McLennan Companies had a net margin of 15.42% and a return on equity of 31.60%. Marsh & McLennan Companies’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the business earned $1.87 EPS. Sell-side analysts anticipate that Marsh & McLennan Companies, Inc. will post 9.61 earnings per share for the current fiscal year.

Marsh & McLennan Companies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Thursday, April 9th will be given a $0.90 dividend. The ex-dividend date is Thursday, April 9th. This represents a $3.60 annualized dividend and a yield of 2.0%. Marsh & McLennan Companies’s dividend payout ratio is presently 42.70%.

Insider Buying and Selling

In related news, CEO John Q. Doyle sold 16,655 shares of Marsh & McLennan Companies stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.35% of the company’s stock.

Analyst Upgrades and Downgrades

MRSH has been the subject of a number of recent research reports. Wells Fargo & Company lifted their price objective on Marsh & McLennan Companies from $199.00 to $203.00 and gave the company an “equal weight” rating in a research note on Friday, January 30th. JPMorgan Chase & Co. cut their price target on Marsh & McLennan Companies from $242.00 to $226.00 and set an “overweight” rating for the company in a research note on Wednesday, January 7th. Evercore dropped their price objective on Marsh & McLennan Companies from $237.00 to $236.00 and set an “outperform” rating on the stock in a report on Wednesday, January 7th. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $200.00 price target on shares of Marsh & McLennan Companies in a report on Friday, January 30th. Finally, Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price target on the stock in a report on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $216.18.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.